Trials / Not Yet Recruiting
Not Yet RecruitingNCT07536061
A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Effect of SRP-1005 in Subjects With Huntington's Disease (INSIGHTT)
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Sarepta Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SRP-1005 | Subcutaneous injection |
| DRUG | Placebo | Subcutaneous injection |
Timeline
- Start date
- 2026-05-05
- Primary completion
- 2027-11-30
- Completion
- 2027-11-30
- First posted
- 2026-04-17
- Last updated
- 2026-04-17
Locations
2 sites across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT07536061. Inclusion in this directory is not an endorsement.